Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026)
Perspective Therapeutics (CATX) posted Change in Interest Receivables of $392000.0 for Q1 2026, up 340.49% sequentially from -$163000.0 in Q4 2025, and up 429.73% YoY from $74000.0 in Q1 2025.
Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026) Analysis & Trends
Perspective Therapeutics has reported Change in Interest Receivables for 3 years, with the latest figure at $392000.0 in Q1 2026.
- Quarterly Change in Interest Receivables rose 429.73% year-over-year to $392000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $460000.0 (down 51.78% YoY) and the FY2025 annual result came in at $142000.0, down 83.86% from the prior year.
- Change in Interest Receivables improved to $392000.0 in Q1 2026 per CATX's latest filing, from -$163000.0 in the prior quarter.
- Over five years, Change in Interest Receivables peaked at $880000.0 in Q4 2024 and troughed at -$163000.0 in Q4 2025.
- A 3-year average of $235666.7 and a median of $143000.0 in 2025 frame the typical range for Change in Interest Receivables.
- The sharpest annual moves came in 2025 and 2026: Change in Interest Receivables tumbled 118.52% in 2025, then surged 429.73% in 2026.
- Over 3 years, Change in Interest Receivables stood at $880000.0 in 2024, then sank by 118.52% to -$163000.0 in 2025, then soared by 340.49% to $392000.0 in 2026.
- According to Business Quant data, Change in Interest Receivables over the past three periods registered $392000.0, -$163000.0, and $19000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | Perspective Therapeutics | 389.10 Mn | 389.10 Mn | - | -142,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -142,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | -163,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | 212,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 880,000.00 |